Literature DB >> 27107104

Are the TR46/Y121F/T289A Mutations in Azole-Resistant Aspergillosis Patient Acquired or Environmental?

Jochem B Buil1, Jacques F Meis2, Willem J G Melchers1, Paul E Verweij3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27107104      PMCID： PMC4862540          DOI： 10.1128/AAC.00256-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  12 in total

Review 1.  Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature.

Authors:  Simone M T Camps; Jan W M van der Linden; Yi Li; Ed J Kuijper; Jaap T van Dissel; Paul E Verweij; Willem J G Melchers
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

2.  Comparison of two highly discriminatory molecular fingerprinting assays for analysis of multiple Aspergillus fumigatus isolates from patients with invasive aspergillosis.

Authors:  Hanneke A de Valk; Jacques F G M Meis; Ben E de Pauw; Peter J Donnelly; Corné H W Klaassen
Journal:  J Clin Microbiol       Date:  2007-03-21       Impact factor: 5.948

Review 3.  Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms.

Authors:  Anuradha Chowdhary; Cheshta Sharma; Ferry Hagen; Jacques F Meis
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

4.  International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus.

Authors:  Paul E Verweij; Michelle Ananda-Rajah; David Andes; Maiken C Arendrup; Roger J Brüggemann; Anuradha Chowdhary; Oliver A Cornely; David W Denning; Andreas H Groll; Koichi Izumikawa; Bart Jan Kullberg; Katrien Lagrou; Johan Maertens; Jacques F Meis; Pippa Newton; Iain Page; Seyedmojtaba Seyedmousavi; Donald C Sheppard; Claudio Viscoli; Adilia Warris; J Peter Donnelly
Journal:  Drug Resist Updat       Date:  2015-08-07       Impact factor: 18.500

5.  Molecular Characterization of a Voriconazole-Resistant, Posaconazole-Susceptible Aspergillus fumigatus Isolate in a Lung Transplant Recipient in the United States.

Authors:  Jose A Vazquez; Elias K Manavathu
Journal:  Antimicrob Agents Chemother       Date:  2015-11-16       Impact factor: 5.191

6.  Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?

Authors:  Paul E Verweij; Eveline Snelders; Gert H J Kema; Emilia Mellado; Willem J G Melchers
Journal:  Lancet Infect Dis       Date:  2009-12       Impact factor: 25.071

7.  Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles.

Authors:  Jan W M van der Linden; Simone M T Camps; Greetje A Kampinga; Jan P A Arends; Yvette J Debets-Ossenkopp; Pieter J A Haas; Bart J A Rijnders; Ed J Kuijper; Frank H van Tiel; János Varga; Anna Karawajczyk; J Zoll; Willem J G Melchers; Paul E Verweij
Journal:  Clin Infect Dis       Date:  2013-05-10       Impact factor: 9.079

8.  First Detection of TR34 L98H and TR46 Y121F T289A Cyp51 Mutations in Aspergillus fumigatus Isolates in the United States.

Authors:  Nathan P Wiederhold; Veronica Garcia Gil; Felipe Gutierrez; Jonathan R Lindner; Mohammad T Albataineh; Dora I McCarthy; Carmita Sanders; Hongxin Fan; Annette W Fothergill; Deanna A Sutton
Journal:  J Clin Microbiol       Date:  2015-10-21       Impact factor: 5.948

Review 9.  Azole Resistance in Aspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles?

Authors:  Paul E Verweij; Anuradha Chowdhary; Willem J G Melchers; Jacques F Meis
Journal:  Clin Infect Dis       Date:  2015-10-20       Impact factor: 9.079

10.  Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure.

Authors:  Susan J Howard; Dasa Cerar; Michael J Anderson; Ahmed Albarrag; Matthew C Fisher; Alessandro C Pasqualotto; Michel Laverdiere; Maiken C Arendrup; David S Perlin; David W Denning
Journal:  Emerg Infect Dis       Date:  2009-07       Impact factor: 6.883
View more
  6 in total

1.  Reply to "Are the TR46/Y121F/T289A Mutations in Azole-Resistant Aspergillosis Patient Acquired or Environmental?".

Authors:  Jose A Vazquez; Elias K Manavathu
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

2.  Rapidly expanded partially HLA DRB1-matched fungus-specific T cells mediate in vitro and in vivo antifungal activity.

Authors:  Gloria Castellano-González; Helen M McGuire; Fabio Luciani; Leighton E Clancy; Ziduo Li; Selmir Avdic; Brendan Hughes; Mandeep Singh; Barbara Fazekas de St Groth; Giorgia Renga; Marilena Pariano; Marina M Bellet; Luigina Romani; David J Gottlieb
Journal:  Blood Adv       Date:  2020-07-28

3.  Unravelling the Molecular Identification and Antifungal Susceptibility Profiles of Aspergillus spp. Isolated from Chronic Pulmonary Aspergillosis Patients in Jakarta, Indonesia: The Emergence of Cryptic Species.

Authors:  Anna Rozaliyani; Asriyani Abdullah; Findra Setianingrum; Wellyzar Sjamsuridzal; Retno Wahyuningsih; Anom Bowolaksono; Ayu Eka Fatril; Robiatul Adawiyah; Mulyati Tugiran; Ridhawati Syam; Heri Wibowo; Chris Kosmidis; David W Denning
Journal:  J Fungi (Basel)       Date:  2022-04-16

4.  Azole-resistant Aspergillus fumigatus harboring TR34/L98H, TR46/Y121F/T289A and TR53 mutations related to flower fields in Colombia.

Authors:  Carlos Alvarez-Moreno; Rose-Anne Lavergne; Ferry Hagen; Florent Morio; Jacques F Meis; Patrice Le Pape
Journal:  Sci Rep       Date:  2017-03-30       Impact factor: 4.379

5.  Nonrandom Distribution of Azole Resistance across the Global Population of Aspergillus fumigatus.

Authors:  Thomas R Sewell; Jianing Zhu; Johanna Rhodes; Ferry Hagen; Jacques F Meis; Matthew C Fisher; Thibaut Jombart
Journal:  mBio       Date:  2019-05-21       Impact factor: 7.867

6.  Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015.

Authors:  Sang Taek Heo; Alexander M Tatara; Cristina Jiménez-Ortigosa; Ying Jiang; Russell E Lewis; Jeffrey Tarrand; Frank Tverdek; Nathaniel D Albert; Paul E Verweij; Jacques F Meis; Antonios G Mikos; David S Perlin; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2017-07-15       Impact factor: 9.079
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.